UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Acta obstetricia et gynecologica Scandinavica, 2012-04, Vol.91 (4), p.496-502

2012

Volltextzugriff (PDF)

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2023-10, Vol.131 (10), p.536-542

2023

Volltextzugriff (PDF)

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-01, Vol.121 (1), p.38-44

2013

Volltextzugriff (PDF)

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Cancer, 2003-07, Vol.98 (1), p.66-73

2003

Volltextzugriff (PDF)

Serum YKL-40 and gestational diabetes - an observational cohort study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-09, Vol.124 (9), p.770-775

2016

Volltextzugriff (PDF)

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2006-10, Vol.114 (10), p.675-681

2006

Volltextzugriff (PDF)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-05, Vol.116 (5), p.400-409

2008

Volltextzugriff (PDF)

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2003-03, Vol.82 (3), p.287-293

2003

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-08, Vol.118 (8), p.557-564

2010

Volltextzugriff (PDF)

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

Cancer, 2004-06, Vol.100 (11), p.2387-2395

2004

Volltextzugriff (PDF)

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2015-05, Vol.123 (5), p.401-409

2015

Volltextzugriff (PDF)

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-12, Vol.121 (12), p.1177-1186

2013

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-10, Vol.120 (10), p.846-854

2012

Volltextzugriff (PDF)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas : From the Danish Malova Ovarian Cancer Study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2008-05, Vol.116 (5), p.400-409

2008

Volltextzugriff (PDF)

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-08, Vol.110 (7-8), p.545-553

2002

Volltextzugriff (PDF)

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

International journal of cancer, 2000-11, Vol.89 (6), p.519-523

2000

Volltextzugriff (PDF)

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma

Cancer, 2004-06, Vol.100 (11), p.2387-2395

2004

Volltextzugriff (PDF)

Limited prognostic value of tissue protein expression levels of cyclin E in D anish ovarian cancer patients: from the D anish ‘ MALOVA ’ ovarian cancer study

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2012-10, Vol.120 (10), p.846-854

2012

Volltextzugriff (PDF)

Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma

Cancer, 2003-07, Vol.98 (1), p.66-73

2003

Volltextzugriff (PDF)

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2003, Vol.82 (3), p.287-293

2003

Volltextzugriff (PDF)

P 53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-08, Vol.110 (7-8), p.545-553

2002

Volltextzugriff (PDF)

Exome sequencing of 22 genes using tissue from patients with biliary tract cancer

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2020-01, Vol.128 (1), p.3-9

2020

Volltextzugriff (PDF)

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

International journal of cancer, 2023-05, Vol.152 (10), p.2145-2152

2023

Volltextzugriff (PDF)

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status

International journal of cancer, 2021-05, Vol.148 (10), p.2542-2556

2021

Volltextzugriff (PDF)

Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies

International journal of cancer, 2017-06, Vol.140 (11), p.2422-2435

2017

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass

Are we ready for translational research based on material and data from the Danish CancerBiobank and can we gain new knowledge from biobank registration?

Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?

Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma: From the Danish MALOVA Ovarian Cancer Study

Serum YKL-40 and gestational diabetes - an observational cohort study

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

Limited prognostic value of tissue protein expression levels of BCl-2 in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: From the danish MALOVA ovarian carcinoma study

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study

Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study

Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish 'MALOVA' ovarian cancer study

Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas : From the Danish Malova Ovarian Cancer Study

P53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass

Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma

Limited prognostic value of tissue protein expression levels of cyclin E in D anish ovarian cancer patients: from the D anish ‘ MALOVA ’ ovarian cancer study

Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma

Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer

P 53 autoantibodies in sera from Danish ovarian cancer patients and their correlation with clinical data and prognosis

Exome sequencing of 22 genes using tissue from patients with biliary tract cancer

Therapy with pembrolizumab in treatment‐naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status

Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies

Aktive Filter

Suchergebnisse filtern